• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷氨酰胺环化酶的抑制作用会改变哺乳动物细胞中焦谷氨酸的形成。

Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells.

作者信息

Cynis Holger, Schilling Stephan, Bodnár Mandy, Hoffmann Torsten, Heiser Ulrich, Saido Takaomi C, Demuth Hans-Ulrich

机构信息

Probiodrug AG, Weinbergweg 22, 06120 Halle/Saale, Germany.

出版信息

Biochim Biophys Acta. 2006 Oct;1764(10):1618-25. doi: 10.1016/j.bbapap.2006.08.003. Epub 2006 Aug 16.

DOI:10.1016/j.bbapap.2006.08.003
PMID:17005457
Abstract

Mammalian cell lines were examined concerning their Glutaminyl Cyclase (QC) activity using a HPLC method. The enzyme activity was suppressed by a QC specific inhibitor in all homogenates. Aim of the study was to prove whether inhibition of QC modifies the posttranslational maturation of N-glutamine and N-glutamate peptide substrates. Therefore, the impact of QC-inhibition on amino-terminal pyroglutamate (pGlu) formation of the modified amyloid peptides Abeta(N3E-42) and Abeta(N3Q-42) was investigated. These amyloid-beta peptides were expressed as fusion proteins with either the pre-pro sequence of TRH, to be released by a prohormone convertase, or as engineered amyloid precursor protein for subsequent liberation of Abeta(N3Q-42) after beta- and gamma-secretase cleavage during posttranslational processing. Inhibition of QC leads in both expression systems to significantly reduced pGlu-formation of differently processed Abeta-peptides. This reveals the importance of QC-activity during cellular maturation of pGlu-containing peptides. Thus, QC-inhibition should impact bioactivity, stability or even toxicity of pyroglutamyl peptides preventing glutamine and glutamate cyclization.

摘要

采用高效液相色谱法检测了哺乳动物细胞系的谷氨酰胺环化酶(QC)活性。在所有匀浆中,该酶活性均被QC特异性抑制剂所抑制。本研究的目的是证明抑制QC是否会改变N - 谷氨酰胺和N - 谷氨酸肽底物的翻译后成熟过程。因此,研究了QC抑制对修饰的淀粉样肽Abeta(N3E - 42)和Abeta(N3Q - 42)氨基末端焦谷氨酸(pGlu)形成的影响。这些淀粉样β肽表达为与促甲状腺激素释放激素(TRH)的前原序列融合的蛋白,由激素原转化酶释放,或者表达为工程化淀粉样前体蛋白,以便在翻译后加工过程中经β和γ分泌酶切割后随后释放Abeta(N3Q - 42)。在两种表达系统中,抑制QC均导致不同加工的Abeta肽的pGlu形成显著减少。这揭示了QC活性在含pGlu肽的细胞成熟过程中的重要性。因此,抑制QC应会影响焦谷氨酰肽的生物活性、稳定性甚至毒性,从而阻止谷氨酰胺和谷氨酸环化。

相似文献

1
Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells.谷氨酰胺环化酶的抑制作用会改变哺乳动物细胞中焦谷氨酸的形成。
Biochim Biophys Acta. 2006 Oct;1764(10):1618-25. doi: 10.1016/j.bbapap.2006.08.003. Epub 2006 Aug 16.
2
Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.淀粉样前体蛋白的淀粉样生成加工:谷氨酰胺环化酶在焦谷氨酸修饰的淀粉样β蛋白生成中起关键作用的证据。
Biochemistry. 2008 Jul 15;47(28):7405-13. doi: 10.1021/bi800250p. Epub 2008 Jun 21.
3
Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ.抑制谷氨酰胺环化酶可防止在体内/原位进行皮质内/海马微量注射后pGlu-Aβ的形成。
J Neurochem. 2008 Aug;106(3):1225-36. doi: 10.1111/j.1471-4159.2008.05471.x. Epub 2008 Jul 8.
4
Pyroglutamate-amyloid-β and glutaminyl cyclase are colocalized with amyloid-β in secretory vesicles and undergo activity-dependent, regulated secretion.焦谷氨酸淀粉样β蛋白和谷氨酰胺环化酶与淀粉样β蛋白共定位于分泌囊泡中,并经历活性依赖性的、受调控的分泌过程。
Neurodegener Dis. 2014;14(2):85-97. doi: 10.1159/000358430. Epub 2014 Jun 18.
5
Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.人皮质中的谷氨酰胺环化酶:与阿尔茨海默病中(pGlu)-淀粉样β负荷和认知衰退的相关性。
J Alzheimers Dis. 2014;39(2):385-400. doi: 10.3233/JAD-131535.
6
Concerted action of dipeptidyl peptidase IV and glutaminyl cyclase results in formation of pyroglutamate-modified amyloid peptides in vitro.二肽基肽酶 IV 和谷氨酰胺酰环化酶的协同作用导致体外生成焦谷氨酸修饰的淀粉样肽。
Neurochem Int. 2018 Feb;113:112-119. doi: 10.1016/j.neuint.2017.12.001. Epub 2017 Dec 7.
7
Dipeptidyl-Peptidase Activity of Meprin β Links N-truncation of Aβ with Glutaminyl Cyclase-Catalyzed pGlu-Aβ Formation.Meprin β 的二肽基肽酶活性将 Aβ 的 N 末端截断与谷氨酰胺环化酶催化的 pGlu-Aβ 形成联系起来。
J Alzheimers Dis. 2018;66(1):359-375. doi: 10.3233/JAD-171183.
8
Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms.谷氨酰胺酰基环化酶通过不同的细胞机制促进海马区局灶性和弥漫性焦谷氨酸(pGlu)-Aβ沉积的形成。
Acta Neuropathol. 2011 Jun;121(6):705-19. doi: 10.1007/s00401-011-0806-2. Epub 2011 Feb 8.
9
Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation.APP 转基因小鼠的免疫组化证据表明谷氨酰胺环化酶是减少 pE-Aβ形成的药物靶点。
Molecules. 2018 Apr 17;23(4):924. doi: 10.3390/molecules23040924.
10
Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice.谷氨酰胺酰环化酶(负责生成焦谷氨酸 Aβ 的酶)过度表达可导致行为缺陷,而谷氨酰胺酰环化酶敲除可挽救 5XFAD 小鼠的行为表型。
J Biol Chem. 2011 Feb 11;286(6):4454-60. doi: 10.1074/jbc.M110.185819. Epub 2010 Dec 10.

引用本文的文献

1
Metabolic resistance of Aβ3pE-42, a target epitope of the anti-Alzheimer therapeutic antibody, donanemab.淀粉样蛋白β 3pE-42 的代谢抵抗性,一种抗阿尔茨海默病治疗性抗体,多纳单抗的靶抗原表位。
Life Sci Alliance. 2024 Sep 30;7(12). doi: 10.26508/lsa.202402650. Print 2024 Dec.
2
The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer's Disease.非典型淀粉样β 异构体在阿尔茨海默病中的隐匿作用。
Cells. 2022 Oct 29;11(21):3421. doi: 10.3390/cells11213421.
3
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease.焦谷氨酸 Aβ级联作为阿尔茨海默病的药物靶点。
Mol Psychiatry. 2022 Apr;27(4):1880-1885. doi: 10.1038/s41380-021-01409-2. Epub 2021 Dec 8.
4
Neuron Loss in Alzheimer's Disease: Translation in Transgenic Mouse Models.阿尔茨海默病中的神经元丧失:在转基因小鼠模型中的转化。
Int J Mol Sci. 2020 Oct 30;21(21):8144. doi: 10.3390/ijms21218144.
5
Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation.APP 转基因小鼠的免疫组化证据表明谷氨酰胺环化酶是减少 pE-Aβ形成的药物靶点。
Molecules. 2018 Apr 17;23(4):924. doi: 10.3390/molecules23040924.
6
N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity.CX3CL1 的 N 端焦谷氨酸的形成对于其完全的生物学活性是必需的。
Biosci Rep. 2017 Aug 23;37(4). doi: 10.1042/BSR20170712. Print 2017 Aug 31.
7
Natural Products from Microalgae with Potential against Alzheimer's Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors.具有抗阿尔茨海默病潜力的微藻天然产物:硫脂是有效的谷氨酰胺环化酶抑制剂。
Mar Drugs. 2016 Nov 2;14(11):203. doi: 10.3390/md14110203.
8
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.pGluAβ 可增加体内 Aβ 的积累,并使其毒性恶化。
Acta Neuropathol Commun. 2016 Oct 7;4(1):109. doi: 10.1186/s40478-016-0380-x.
9
Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons.淀粉样β肽Aβ3pE-42诱导神经元中的脂质过氧化、膜通透性增加和钙内流。
J Biol Chem. 2016 Mar 18;291(12):6134-45. doi: 10.1074/jbc.M115.655183. Epub 2015 Dec 23.
10
Pyroglutamyl-N-terminal prion protein fragments in sheep brain following the development of transmissible spongiform encephalopathies.传染性海绵状脑病发生后绵羊脑中的焦谷氨酸-N-端朊蛋白片段。
Front Mol Biosci. 2015 Mar 11;2:7. doi: 10.3389/fmolb.2015.00007. eCollection 2015.